PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91021F00004Advance universal influenza vaccine - FLU — Leidos Biomedical Research, Inc

Leidos Biomedical Research, Inc holds $2.1B across 186 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 75N91019D00024. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Jan 28, 2031 PoP end — agencies typically plan 12–18 months ahead.

Nih Nci

Awarding office

Leidos Biomedical Research, Inc

Recipient

Jan 28, 2031

PoP end

$121.4M

Obligated

541715

NAICS

AN12

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Leidos Biomedical Research, Inc — $90

Contract facts

NONE

Contract number75N91021F00004

Also listed as75N91019D00024-75N91021F00004

AgencyNih Nci

Awarding officeNih Nci

IncumbentLeidos Biomedical Research, Inc

UEIHV8BH9BPG8Y9

NAICS541715

PSCAN12

Parent IDIQ / IDV75N91019D00024

Place of performanceFREDERICK, MD

PoP end (current)Jan 28, 2031

Obligated$121.4M

ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2) is a federal NONE award for Nih Nci held by Leidos Biomedical Research, Inc. Estimated value $141.7M ($121.4M obligated). Current period of performance ends Jan 28, 2031. Last award drew 1 bidder. Place of performance: FREDERICK, MD.

ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)

Recompete timing

Public

● Expiring in 1622 days

Current PoP ends Jan 28, 2031 (1622 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Jul 28, 2029.

Incumbent footprint

Public record

Leidos Biomedical Research, Inc — $2.1B obligated across 186 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$2.1B · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

75N91021F00013

ENABLING NCI CLINICAL & RESEARCH DATA SHARING

Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.

$81.1M

Aug 31, 2026

75N91020F00026

DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS

Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.

$56.5M

May 25, 2027

75N91020F00009

ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW…

Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.

$89.6M

Jul 31, 2028

75N91020F00025

DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT,…

Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.

$97.5M

Sep 24, 2028

75N91019F00139

MD NET

Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.

$163.5M

Sep 29, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N91021F00004?

75N91021F00004 (Advance universal influenza vaccine - FLU) is a Nih Nci award with an estimated value of $141.7M, currently held by Leidos Biomedical Research, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91021F00004?

Nih Nci awarded 75N91021F00004 to Leidos Biomedical Research, Inc.

Who is the incumbent on 75N91021F00004?

Leidos Biomedical Research, Inc is the incumbent with $2.1B across 186 related awards in SCOUT’s public footprint. The current period of performance ends Jan 28, 2031.

When does Leidos Biomedical Research, Inc’s 75N91021F00004 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 28, 2031. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action Jul 29, 2026